$RYET - $9.3M-$9.5M H1 Revenue, an $880K AI Deployment and a New 10 percent Royalty Deal

RYET just guided to $9.3M-$9.5M in preliminary H1 FY2027 revenue, up more than 24x YoY from about $0.37M in H1 FY2026 and already above the $7.48M generated in all of FY2026.

At the same time, the company delivered its $880K YeeZo deployment covering 10 AIGC labs and 610 workstations.

Now Cogni AI is expanding into Malaysian healthcare through a definitive licensing deal with $BGLC that includes a 10 percent royalty on qualifying technology receipts.

That gives RYET three things moving at once: core revenue growth, direct AI deployment revenue and a new international licensing model.

Latest press release name: "RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab"